Jun 07, 2026, 17:30 ET CagriSema, a once-weekly investigational treatment that combines a novel amylin analog with a GLP-1 receptor agonist (RA), achieved significant reductions in HbA 1c and bodyweight versus comparators across three phase 3 trials in adults with type 2 diabetes (T2D) 1-3 Data from the REIMAGINE clinical development program, a series of phase 3 trials evaluating once-weekly CagriSema in adults with T2D across various stages of their disease, were presented at an ADA symposium 1-3 Novo Nordisk continues to demonstrate pioneering leadership and scientific innovation through advancing diabetes research PLAINSBORO, N.J
PMID 25387
Clinical Update 6/18/2019 Fish Oil for Heart Failure
The CoA for this product is batch-specific issued by the testing laboratory, not generated by Woosh
GHK-CU peptide therapy represents a powerful approach to supporting the bodys natural ability to repair, regenerate, and maintain youthful function at the cellular level
How to Use a Hydra Needle to Micro-Inject Topical Peptides for Firmer, Smoother Skin Share A Complete Shopify Guide Featuring IM FABULOUS COSMETICS GHK-Cu and SNAP-8 In the world of advanced skincare, micro-delivery systems are redefining how active ingredients perform